The proposed Canary Staked INJ ETF would actively stake its INJ holdings on the Injective proof-of-stake network, passing staking rewards, currently estimated at 10% to 12% annually, directly to shareholders.
It also signals growing market confidence in Injective’s ecosystem, which has attracted strategic backing from firms like Google Cloud and T-Mobile.
Injective Labs is also actively engaged in ongoing discussions with U.S. regulators to define compliant pathways for decentralized finance.
